Your browser doesn't support javascript.
loading
Nanoparticulate Impurities in Pharmaceutical-Grade Sugars and their Interference with Light Scattering-Based Analysis of Protein Formulations.
Weinbuch, Daniel; Cheung, Jason K; Ketelaars, Jurgen; Filipe, Vasco; Hawe, Andrea; den Engelsman, John; Jiskoot, Wim.
Afiliación
  • Weinbuch D; Coriolis Pharma, Am Klopferspitz 19, 82152, Martinsried-Munich, Germany.
Pharm Res ; 32(7): 2419-27, 2015 Jul.
Article en En | MEDLINE | ID: mdl-25630820
PURPOSE: In the present study we investigated the root-cause of an interference signal (100-200 nm) of sugar-containing solutions in dynamic light scattering (DLS) and nanoparticle tracking analysis (NTA) and its consequences for the analysis of particles in biopharmaceutical drug products. METHODS: Different sugars as well as sucrose of various purity grades, suppliers and lots were analyzed by DLS and NTA before and (only for sucrose) after treatment by ultrafiltration and diafiltration. Furthermore, Fourier transform infrared (FTIR) microscopy, scanning electron microscopy coupled energy-dispersive X-ray spectroscopy (SEM-EDX), and fluorescence spectroscopy were employed. RESULTS: The intensity of the interference signal differed between sugar types, sucrose of various purity grades, suppliers, and batches of the same supplier. The interference signal could be successfully eliminated from a sucrose solution by ultrafiltration (0.02 µm pore size). Nanoparticles, apparently composed of dextrans, ash components and aromatic colorants that were not completely removed during the sugar refinement process, were found responsible for the interference and were successfully purified from sucrose solutions. CONCLUSIONS: The interference signal of sugar-containing solutions in DLS and NTA is due to the presence of nanoparticulate impurities. The nanoparticles present in sucrose were identified as agglomerates of various impurities originating from raw materials.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Biofarmacia / Carbohidratos / Muramidasa / Contaminación de Medicamentos / Nanopartículas / Dispersión Dinámica de Luz Tipo de estudio: Prognostic_studies Idioma: En Revista: Pharm Res Año: 2015 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Biofarmacia / Carbohidratos / Muramidasa / Contaminación de Medicamentos / Nanopartículas / Dispersión Dinámica de Luz Tipo de estudio: Prognostic_studies Idioma: En Revista: Pharm Res Año: 2015 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos